Genetic variants affecting T2D risk and glucose levels were significantly enriched in glucocorticoid-responsive chromatin sites, including a likely causal variant at the SIX2/3 locus which had glucocorticoid-dependent effects on beta cell enhancer activity and affected SIX2 and SIX3 expression. This evidence concerns the gene SIX2 and type 2 diabetes mellitus.